Related references
Note: Only part of the references are listed.The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation
Li Di et al.
AAPS JOURNAL (2021)
Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities
Sana Javaid et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cytochrome P450 CYP2E1 Suppression Ameliorates Cerebral Ischemia Reperfusion Injury
Jin Yu et al.
ANTIOXIDANTS (2021)
Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-eclampsia
Yasuo Uchida et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)
Participation of Monocarboxylate Transporter 8, But Not P-Glycoprotein, in Carrier-Mediated Cerebral Elimination of Phenytoin across the Blood-Brain Barrier
Ryuta Jomura et al.
PHARMACEUTICAL RESEARCH (2021)
Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes
Yasuo Uchida et al.
DRUG METABOLISM AND DISPOSITION (2020)
Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats
Yasuo Uchida et al.
MOLECULAR PHARMACEUTICS (2020)
L-Type amino acid transporter 1 as a target for drug delivery
Elena Puris et al.
PHARMACEUTICAL RESEARCH (2020)
Establishment and validation of highly accurate formalin-fixed paraffin-embedded quantitative proteomics by heat-compatible pressure cycling technology using phase-transfer surfactant and SWATH-MS
Yasuo Uchida et al.
SCIENTIFIC REPORTS (2020)
Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis
Yasuo Uchida et al.
MOLECULAR NEUROBIOLOGY (2019)
Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy
Ralf G. Rempe et al.
JOURNAL OF NEUROSCIENCE (2018)
Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line
Yu Takahashi et al.
PHARMACEUTICAL RESEARCH (2018)
A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2
Kristian Jensen et al.
MODERN PATHOLOGY (2017)
Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness
Kohsuke Gonda et al.
SCIENTIFIC REPORTS (2017)
Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients
Vincent L. M. Yip et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy?
Ruba Benini et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2016)
Seizures and Epilepsy: An Overview for Neuroscientists
Carl E. Stafstrom et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man
Petra Malatkova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures
Felippe Borlot et al.
EPILEPSY RESEARCH (2014)
EFFECT OF STATUS EPILEPTICUS AND ANTIEPILEPTIC DRUGS ON CYP2E1 BRAIN EXPRESSION
B. Boussadia et al.
NEUROSCIENCE (2014)
Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype
Hitomi Ohmura-Kakutani et al.
PLOS ONE (2014)
Pharmacoproteomics-Based Reconstruction of In Vivo P-Glycoprotein Function at Blood-Brain Barrier and Brain Distribution of Substrate Verapamil in Pentylenetetrazole-Kindled Epilepsy, Spontaneous Epilepsy, and Phenytoin Treatment Models
Yasuo Uchida et al.
DRUG METABOLISM AND DISPOSITION (2014)
Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
Yasuo Uchida et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Transport of gabapentin by LAT1 (SLC7A5)
David Dickens et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models
Haruka Nakanishi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice
Yasuo Uchida et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy
Joan Y. W. Liu et al.
BRAIN (2012)
Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis
Ludovic C. Gillet et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Quantitative Membrane Protein Expression at the Blood-Brain Barrier of Adult and Younger Cynomolgus Monkeys
Katsuaki Ito et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
Ramzi Shawahna et al.
MOLECULAR PHARMACEUTICS (2011)
Blood-Brain Barrier (BBB) Pharmacoproteomics: Reconstruction of In Vivo Brain Distribution of 11 P-Glycoprotein Substrates Based on the BBB Transporter Protein Concentration, In Vitro Intrinsic Transport Activity, and Unbound Fraction in Plasma and Brain in Mice
Yasuo Uchida et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Quantitative atlas of membrane transporter proteins:: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria
Junichi Kamiie et al.
PHARMACEUTICAL RESEARCH (2008)
P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier
Atsushi Ose et al.
DRUG METABOLISM AND DISPOSITION (2008)
Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model
Jarogniew J. Luszczki et al.
EPILEPSY RESEARCH (2007)
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy
E. A. van Vliet et al.
BRAIN (2007)
Limited P-glycoprotein mediated efflux for anti-epileptic drugs
Andrew Crowe et al.
JOURNAL OF DRUG TARGETING (2006)
The potential of pharmacogenetics in the treatment of epilepsy
C Depondt
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2006)
Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: Concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity
R Clinckers et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes
K Bachmann et al.
XENOBIOTICA (2003)
Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro
IM Kapetanovic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier:: evidence from microdialysis experiments in rats
H Potschka et al.
NEUROSCIENCE LETTERS (2002)
Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance
M Rizzi et al.
JOURNAL OF NEUROSCIENCE (2002)
Share Paper
